GDF11 as a friend or an enemy in the cancer biology?

[1]  Haikou Tang,et al.  GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERα signaling. , 2022, Neoplasma.

[2]  Huixian Liu,et al.  Circular RNAs in cholangiocarcinoma. , 2022, Cancer letters.

[3]  Jibiao Wu,et al.  Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Fengjuan Liu,et al.  GDF11 Regulates PC12 Neural Stem Cells via ALK5-Dependent PI3K-Akt Signaling Pathway , 2022, International journal of molecular sciences.

[5]  Yang Wang,et al.  Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III. , 2022, European journal of cancer.

[6]  X. Ji,et al.  Quantitative proteomic dataset of whole protein in three melanoma samples of 92.1, 92.1-A and 92.1-B , 2022, Data in brief.

[7]  M. Vinciguerra,et al.  GDF11 inhibits adipogenesis and improves mature adipocytes metabolic function via WNT/β‐catenin and ALK5/SMAD2/3 pathways , 2022, Cell proliferation.

[8]  J. Niu,et al.  Exosome-transmitted miR-3124-5p promotes cholangiocarcinoma development via targeting GDF11 , 2022, Frontiers in Oncology.

[9]  S. Wong,et al.  Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer. , 2022, Cancer treatment and research communications.

[10]  W. Jiang,et al.  Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone , 2022, Computational and structural biotechnology journal.

[11]  Ruijie Ming,et al.  The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins , 2022, Frontiers in Oncology.

[12]  Daniel A. Hu,et al.  Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance , 2022, Genes & diseases.

[13]  Weixian Liu,et al.  NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation , 2022, Cancer biology & therapy.

[14]  Dongjie Chen,et al.  Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma , 2021, Frontiers in Immunology.

[15]  E. O’Reilly,et al.  Pancreatic Cancer: A Review. , 2021, JAMA.

[16]  Kai Wang,et al.  LncRNA LINC01116 facilitates melanoma 1 progression via sequestering miR-3612 and up-regulating GDF11 and SDC3. , 2021, Archives of medical research.

[17]  M. Vinciguerra,et al.  GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[18]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[19]  T. Sun,et al.  4sc‐202 and Ink‐128 cooperate to reverse the epithelial to mesenchymal transition in OSCC , 2020, Oral diseases.

[20]  L. Gómez-Quiroz,et al.  GDF11 restricts aberrant lipogenesis and changes in mitochondrial structure and function in human hepatocellular carcinoma cells , 2020, Journal of cellular physiology.

[21]  Yun‐Sil Lee,et al.  Similar sequences but dissimilar biological functions of GDF11 and myostatin , 2020, Experimental & Molecular Medicine.

[22]  J. Valle,et al.  Pancreatic cancer , 2020, The Lancet.

[23]  S. Joshi,et al.  ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension , 2020, Science Translational Medicine.

[24]  H. Onishi,et al.  Hypoxia and pancreatic ductal adenocarcinoma. , 2020, Cancer letters.

[25]  G. Xue,et al.  Significance of 125I radioactive seed implantation on growth differentiation factor and programmed death receptor-1 during treatment of oral cancer. , 2020, World journal of clinical cases.

[26]  Chongjun Zhong,et al.  MiR-92a regulates endothelial progenitor cells (EPCs) by targeting GDF11 via activate SMAD2/3/FAK/Akt/eNOS pathway. , 2019, Annals of translational medicine.

[27]  L. Peyrin-Biroulet,et al.  Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 , 2019, International journal of cancer.

[28]  L. Gómez-Quiroz,et al.  GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[29]  Zijiao Song,et al.  Metformin inhibits TGF‐beta 1‐induced MCP‐1 expression through BAMBI‐mediated suppression of MEK/ERK1/2 signalling , 2019, Nephrology.

[30]  G. Frühbeck,et al.  Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes , 2019, Aging.

[31]  Chia-Wei Lin,et al.  Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia–reperfusion injury , 2019, Basic Research in Cardiology.

[32]  Jie Tian,et al.  GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma , 2019, PloS one.

[33]  W. Jing,et al.  GDF11 restrains tumor growth by promoting apoptosis in pancreatic cancer , 2018, OncoTargets and therapy.

[34]  W. Yuan,et al.  Effect of exosomal miRNA on cancer biology and clinical applications , 2018, Molecular Cancer.

[35]  Biao Gu,et al.  Effect of GDF11 on proliferation and apoptosis of esophageal cancer cells. , 2018, Cellular and molecular biology.

[36]  Jordan F Hastings,et al.  Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy , 2018, Science Translational Medicine.

[37]  Fengjuan Liu,et al.  GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway , 2018, PeerJ.

[38]  Yvonne Tay,et al.  Noncoding RNA:RNA Regulatory Networks in Cancer , 2018, International journal of molecular sciences.

[39]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[40]  F. Liu,et al.  GDF11/BMP11 as a novel tumor marker for liver cancer. , 2018, Experimental and therapeutic medicine.

[41]  S. Philippou,et al.  Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast. , 2018, Breast.

[42]  K. Janes,et al.  Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer. , 2017, Developmental cell.

[43]  Tielin Yang,et al.  Matrine suppresses cardiac fibrosis by inhibiting the TGF-β/Smad pathway in experimental diabetic cardiomyopathy , 2017, Molecular medicine reports.

[44]  F. Liu,et al.  Role of growth differentiation factor 11 in development, physiology and disease , 2017, Oncotarget.

[45]  L. Yin,et al.  The versatility and paradox of GDF 11 , 2017, Pharmacology & therapeutics.

[46]  B. Barrera-mera,et al.  Hepatic Metastasis from Colorectal Cancer , 2017, Euroasian journal of hepato-gastroenterology.

[47]  Da-hai Yu,et al.  Coexpression of growth differentiation factor 11 and reactive oxygen species in metastatic oral cancer and its role in inducing the epithelial to mesenchymal transition. , 2017, Oral surgery, oral medicine, oral pathology and oral radiology.

[48]  P. Michl,et al.  Esophageal Cancer: New Insights into a Heterogenous Disease , 2017, Digestion.

[49]  Nuno Bonito,et al.  Bone Metastases: An Overview , 2017, Oncology reviews.

[50]  Richard T. Lee,et al.  Structural basis for potency differences between GDF8 and GDF11 , 2017, BMC Biology.

[51]  J. Jing,et al.  GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation , 2016, Nature Communications.

[52]  Richard T. Lee,et al.  Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. , 2016, Circulation research.

[53]  A. Maass,et al.  Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival , 2016, BMC Cancer.

[54]  Yong-Hui Zhang,et al.  GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells , 2016, Oncotarget.

[55]  T. Mueller,et al.  Structural insights into BMP receptors: Specificity, activation and inhibition. , 2016, Cytokine & growth factor reviews.

[56]  S. Houser,et al.  GDF11 does not rescue aging-related pathological hypertrophy. , 2015, Circulation research.

[57]  Katherine M. Weh,et al.  Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation , 2015, Oncotarget.

[58]  I. Clay,et al.  GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. , 2015, Cell metabolism.

[59]  S. Carr,et al.  The extracellular matrix: Tools and insights for the "omics" era. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[60]  Michael J. Kerin,et al.  Effects of Age on the Detection and Management of Breast Cancer , 2015, Cancers.

[61]  H. Bartsch,et al.  The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. , 2015, Hepatobiliary surgery and nutrition.

[62]  T. Borchardt,et al.  Myostatin induces interstitial fibrosis in the heart via TAK1 and p38 , 2015, Cell and Tissue Research.

[63]  Richard T. Lee,et al.  Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle , 2014, Science.

[64]  S. Falconer,et al.  Identification and expression of a novel transcript of the growth and differentiation factor-11 gene , 2014, Molecular and Cellular Biochemistry.

[65]  A. Fricot,et al.  An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia , 2014, Nature Medicine.

[66]  Yun‐Sil Lee,et al.  Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 , 2013, Proceedings of the National Academy of Sciences.

[67]  J. Kim,et al.  Phosphorylated S6 kinase-1: a breast cancer marker predicting resistance to neoadjuvant chemotherapy. , 2013, Anticancer research.

[68]  Guan-Cheng Li,et al.  Tumor markers for hepatocellular carcinoma , 2013, Molecular and clinical oncology.

[69]  Richard T. Lee,et al.  Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy , 2013, Cell.

[70]  Yingtang Shi,et al.  Gdf11 Facilitates Temporal Progression of Neurogenesis in the Developing Spinal Cord , 2011, The Journal of Neuroscience.

[71]  L. Patthy,et al.  WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity , 2010, The FEBS journal.

[72]  A. Mcpherron.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. , 2010, Immunology, endocrine & metabolic agents in medicinal chemistry.

[73]  M. P. Leòn,et al.  Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma , 2010, Journal of Clinical Pathology.

[74]  M. Whitman,et al.  The role and regulation of GDF11 in Smad2 activation during tailbud formation in the Xenopus embryo , 2010, Mechanisms of Development.

[75]  Arthur D Lander,et al.  Foxg1 promotes olfactory neurogenesis by antagonizing Gdf11 , 2009, Development.

[76]  C. Caldas,et al.  The breast cancer somatic 'muta-ome': tackling the complexity , 2009, Breast Cancer Research.

[77]  Nicholas J Shaheen,et al.  Barrett's oesophagus , 2009, The Lancet.

[78]  A. Prat,et al.  In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate , 2008, Proceedings of the National Academy of Sciences.

[79]  S. Kumar,et al.  Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[80]  K. Mimori,et al.  Clinical significance of growth differentiation factor 11 in colorectal cancer. , 2007, International journal of oncology.

[81]  C. Ibáñez,et al.  Growth differentiation factor 11 signals through the transforming growth factor‐β receptor ALK5 to regionalize the anterior–posterior axis , 2006, EMBO reports.

[82]  A. Mukherjee,et al.  Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. , 2006, Endocrinology.

[83]  T. Nishimura,et al.  Decorin binds myostatin and modulates its activity to muscle cells. , 2006, Biochemical and biophysical research communications.

[84]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[85]  M. Matzuk,et al.  GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina , 2005, Science.

[86]  Xueying Gu,et al.  GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development , 2004, Development.

[87]  J. McCubrey,et al.  EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). , 2003, International journal of oncology.

[88]  Anne L. Calof,et al.  Autoregulation of Neurogenesis by GDF11 , 2003, Neuron.

[89]  S. P. Oh,et al.  Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. , 2002, Genes & development.

[90]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[91]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[92]  A. Koong,et al.  Pancreatic tumors show high levels of hypoxia. , 2000, International journal of radiation oncology, biology, physics.

[93]  Se-Jin Lee,et al.  Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.

[94]  A. Joyner,et al.  Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis , 1999, Mechanisms of Development.

[95]  Allan Balmain,et al.  TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.

[96]  John Calvin Reed,et al.  Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. , 1994, Oncogene.

[97]  F. El-Zeky,et al.  Significant changes in the distribution of histologic types of lung cancer a review of 4928 cases , 1990, Cancer.